Unknown

Dataset Information

0

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike.

ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a global pandemic. The antigen specificity and kinetics of the antibody response mounted against this novel virus are not understood in detail. Here, we report that subjects with a more severe SARS-CoV-2 infection exhibit a larger antibody response against the spike and nucleocapsid protein and epitope spreading to subdominant viral antigens, such as open reading frame 8 and non-structural proteins. Subjects with a greater antibody response mounted a larger memory B cell response against the spike, but not the nucleocapsid protein. Additionally, we revealed that antibodies against the spike are still capable of binding the D614G spike mutant and cross-react with the SARS-CoV-1 receptor binding domain. Together, this study reveals that subjects with a more severe SARS-CoV-2 infection exhibit a greater overall antibody response to the spike and nucleocapsid protein and a larger memory B cell response against the spike.

SUBMITTER: Guthmiller JJ 

PROVIDER: S-EPMC7491512 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a global pandemic. The antigen specificity and kinetics of the antibody response mounted against this novel virus are not understood in detail. Here, we report that subjects with a more severe SARS-CoV-2 infection exhibit a larger antibody response against the spike and nucleocapsid protein and epitope spreading to subdominant viral antigens, such as open reading frame 8 and non-structural proteins. Subjects with a  ...[more]

Similar Datasets

Unknown SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
| S-EPMC7845638 | biostudies-literature
Unknown Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection.
| S-EPMC9108258 | biostudies-literature
Unknown Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant.
| S-EPMC9584761 | biostudies-literature
Unknown Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
| S-EPMC7524645 | biostudies-literature
Unknown Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
| S-EPMC8097665 | biostudies-literature
Unknown Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity.
| S-EPMC8168399 | biostudies-literature
Unknown Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
| S-EPMC8359677 | biostudies-literature
Unknown A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
| S-EPMC10562195 | biostudies-literature
Unknown Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2.
| S-EPMC9364715 | biostudies-literature
Unknown Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.
| S-EPMC8472882 | biostudies-literature